Production and launch of Favipiravir and Remdesivir in Actover Pharma group

October 20, 2020

Author: Acteropharma

With continuous monitoring of international research and protocols, it was suggested to produce drugs in the treatment of Covid-19 in the Actover group, as a pioneer in the production of drugs needed in COVID-19, the group unveiled two drugs, Remdesivir and Favipiravir.

It should be noted that these two drugs have entered the official list of drugs in Iran.

Last News

The 23rd National Congress of the Iranian Society of Medical Oncology supported by Actero

November 17, 2024

Author:

Acteropharma

The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital, Tehran, alongside many experienced professors and colleagues from the Blood and Oncology Department.

The 6th International Congress of Uro-Oncology supported by Actero

September 25, 2024

Author:

Acteropharma

The 23rd National Congress of the Iranian Society of Medical Oncology and Hematology was held on 26-24 October 2024 in the conference hall of the Ghalb Hotel, in Shahid Rajaee Hospital

Nahaleh Naraqi honors National Doctors Day in Iran

August 28, 2024

Author:

Acteropharma

Nahale Naraghi honors National Doctors Day in Iran, coinciding with Avicenna’s birthday.